Clin2
NCT06823466Possibly a fitRecruiting

Stroke study for patients on blood thinners

Ischemic StrokeOral AnticoagulationAtrial Fibrillation (AF)Outcome AssessmentClinical Presentations

Part of Brain & nervous system, Heart & circulation clinical trials.

This study looks at people who had a stroke while taking blood thinners (anticoagulants) for an irregular heartbeat. It aims to learn more about these strokes and how to better prevent them in the future.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
200 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You were 18 or older when you had your stroke.
  • Your stroke was confirmed by a doctor as an ischemic stroke (caused by a clot).
  • You had a brain scan (CT or MRI) that showed damage from the stroke.
  • You were taking a blood thinner (like warfarin or apixaban) at the time of your stroke.
  • You have been diagnosed with atrial fibrillation (AF) or another heart rhythm issue that can cause clots.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07609654Not yet recruiting· Phase 4
Blood Thinner Safety After Stroke in Atrial Fibrillation Patients

This study tests whether patients with atrial fibrillation (a heart rhythm disorder) who have had both a previous brain bleed and a recent stroke can safely take blood thinners to prevent future strokes. Researchers want to find the safest approach for people in this high-risk situation.

NCT07626411Recruiting· Phase 3
Blood Thinner Study for Irregular Heartbeat

This study tests a new blood thinner to prevent strokes and blood clots in people with atrial fibrillation (a common heart rhythm problem). You may qualify if you have atrial fibrillation and at least one risk factor for stroke, or if you've never taken a blood thinner before.

Dothan, Alabama
NCT07430956Recruiting· Phase 3
Stroke prevention in atrial fibrillation without standard blood thinners

This trial tests a new medication to prevent strokes and blood clots in people with atrial fibrillation (an irregular heartbeat) who cannot safely take standard blood thinners. The drug works by blocking a different clotting factor, which may lower bleeding risks.

Dothan, Alabama
NCT07011095Not yet recruiting· Early Phase 1
Blood thinner choice after a stroke while on a DOAC

This trial compares two types of blood thinners (DOACs like apixaban or rivaroxaban, and warfarin) to see which works better for people who have a stroke while taking a DOAC. The goal is to find the safest and most effective option to prevent another stroke.

NCT06486792Recruiting· Phase 4
Stroke prevention in patients with hidden atrial fibrillation

This trial tests if starting blood thinners can prevent another stroke in people who had a stroke but were found to have a hidden heart rhythm problem called atrial fibrillation. It is for older adults who have had a recent stroke without a known cause.

Paris, Paris
NCT07713537Recruiting
Stroke risk score for AF patients on blood thinners

This study is testing a new scoring system to predict stroke risk in people with atrial fibrillation who are taking DOAC blood thinners. The goal is to help doctors personalize treatment and prevent blood clots.

Barcelona, Barcelona

Hear when a new Ischemic Stroke trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.